Publication Name	World Journal of Stem Cells
Manuscript ID	27389
Country	Pakistan

Received	2016-05-27 18:21
Peer-Review Started	2016-05-28 18:25
First Decision by Editorial Office Director
Return for Revision	2016-07-06 08:56
Revised	2016-07-15 04:59
Publication Fee Transferred
Second Decision by Editor	2016-07-28 14:53
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2016-08-08 14:40
Articles in Press	2016-08-08 14:40
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-08-12 17:22
Publish the Manuscript Online	2016-08-19 16:02

ISSN	1948-0210 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Review
Article Title	Therapy-related myeloid neoplasms - what have we learned so far?
Manuscript Source	Invited Manuscript
All Author List	Mohammad Faizan Zahid, Aric Parnes, Bipin N Savani, Mark R Litzow and Shahrukh K Hashmi
Funding Agency and Grant Number
Corresponding Author	Mohammad Faizan Zahid, MBBS, Medical College, Aga Khan University, P.O. Box 3500, Stadium road, Karachi 74800, Pakistan. faizanzahid91@hotmail.com
Key Words	Therapy-related acute myeloid leukemia; Therapy-related myelodysplastic syndromes; Ionizing radiation; Alkylating agents; Allogeneic hematopoietic stem cell transplantation; Topoisomerase Ⅱ inhibitors; Therapy-related myeloid neoplasms
Core Tip	Therapy-related myeloid neoplasms are becom-ing an increasing problem as the survival of cancer patients lengthens. The etiology has an important in-fluence on the biological characteristics, time to onset and prognosis of the resultant disease. Although treatment of therapy-related myeloid neoplasms represents a substantial challenge due to prior treatment and comorbidities, cure is possible, especially with allogeneic stem cell transplantation, particularly in those with good-risk karyotype. Ultimately, individual assessment of risk factors may lead to developing risk-adapted therapies to reduce the incidence of this serious complication without affecting therapy for the underlying disorders.
Publish Date	2016-08-19 16:02
Citation	Zahid MF, Parnes A, Savani BN, Litzow MR, Hashmi SK. Therapy-related myeloid neoplasms - what have we learned so far? World J Stem Cells 2016; 8(8): 231-242
URL	http://www.wjgnet.com/1948-0210/full/v8/i8/231.htm
DOI	http://dx.doi.org/10.4252/wjsc.v8.i8.231

Full Article (PDF)	WJSC-8-231.pdf
Full Article (Word)	WJSC-8-231.doc
Manuscript File	27389-Review.docx
Answering Reviewers	27389-Answering reviewers.pdf
Audio Core Tip	27389-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	27389-Conflict-of-interest statement.pdf
Copyright License Agreement	27389-Copyright assignment.pdf
Peer-review Report	27389-Peer-review(s).pdf
Scientific Misconduct Check	27389-Scientific misconduct check.pdf
Scientific Editor Work List	27389-Scientific editor work list.pdf